Cite
HARVARD Citation
Reck, M. et al. (n.d.). 80P Nintedanib (N) + docetaxel (D) after immunotherapy in adenocarcinoma non-small cell lung cancer (NSCLC): First results from the non-interventional LUME-BioNIS study. Annals of oncology. p. . [Online].